Craniopharyngiomas are brain tumors that negatively impact the hormonal function of the nearby pituitary. The tumor location often prevents necessary surgical intervention. Alternative pharmacological ...
Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS therapies, today announced key leadership appointments including its first CSO and CMO, and the expansion ...
Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene (T-SIGn®) therapy platform to deliver novel immunotherapeutic proteins, biomolecules and transgene ...